Skip to main content
. 2017 May 12;12(5):e0177272. doi: 10.1371/journal.pone.0177272

Table 1. Baseline characteristics of the study population, stratified by sex.

Variable Women (N = 2148) Men (N = 1962) P*
Age, years 48.8 (16.1) 49.5 (16.3) 0.14
Age range, years 20–81 20–81 -
Total Testosterone, nmol/L 0.8 (0.6; 1.1) 14.8 (11.4; 19.1) < 0.01
SHBG, nmol/L 83.2 (57.9; 123.9) 46.5 (34.1; 61.2) < 0.01
Calculated Free Testosterone, nmol/L 0.006 (0.004; 0.01) 0.24 (0.19; 0.30) < 0.01
Androstenedione, nmol/L 1.6 (1.0; 2.5) 1.9 (1.4; 2.5) < 0.01
Body Mass Index, kg/m2 26.9 (5.3) 27.6 (4.0) < 0.01
Waist circumference, cm 83.1 (13.1) 95.5 (11.7) < 0.01
Current smoking, % 26.9 35.6 < 0.01
Physically inactive, % 56.5 58.3 0.2
Alcohol consumption, g/day 3.1 (0.7; 7.8) 11.4 (3.3; 26.8) < 0.01
Oral contraceptive use, % 20.2 - -
Hormone replacement therapy, % 20.7 - -
Systolic blood pressure, mmHg 129.9 (21.3) 142.4 (19.4) < 0.01
Diastolic blood pressure, mmHg 80.9 (10.7) 86.1 (11.4) < 0.01
Antihypertensive medication, % 24.3 24.9 0.6
Hypertension, % 42.1 62.3 < 0.01
Antidepressive medication, % 2.7 1.2 0.01
Depressive symptoms, N
Baseline 370 (17.2) 156 (7.9) < 0.01
5-year follow-up 166 (10.0) 73 (5.0) < 0.01
10-year follow-up 114 (9.5) 63 (3.5) < 0.01
Mini mental status, N, score
Baseline 588; 26 (24; 28) 572; 26 (23; 28) 0.5
5-year follow-up 634; 28 (26;29) 573; 28 (27;29) 0.3
10-year follow-up 521; 29 (27;30) 465; 29 (27;29) 0.4

Data are absolute numbers (percentages), mean (SD) or median (Q1, Q3). Oral contraceptive use was defined according to Anatomical Therapeutic Chemical (ATC) classification code G03AA/B/C/D. Values of sex hormones are reported based on availability of each hormone. Total testosterone: women N = 1642, men N = 1555; SHBG: women N = 1982, men N = 1826; androstenedione: women N = 1704, men N = 1517; free testosterone: women N = 1525, men N = 1448.

*Statistical comparisons were performed with χ 2 test (nominal data) or Mann-Whitney-U-test (continuous data).

SHBG, sex hormone-binding globulin.